| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 OR2T5 CCR7 TACR1 NMUR2 PTAFR TAS2R38 OR4K15 GPRC5B OPRD1 OPRK1 | 2.78e-20 | 884 | 48 | 24 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 GRID1 C3AR1 OR2T5 CCR7 TACR1 NMUR2 PTAFR TAS2R38 OR4K15 GPRC5B OPRD1 OPRK1 | 3.27e-17 | 1353 | 48 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.64e-11 | 133 | 48 | 9 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.20e-11 | 140 | 48 | 9 | GO:0001653 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.94e-09 | 53 | 48 | 6 | GO:0008188 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.67e-08 | 37 | 48 | 5 | GO:0042923 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 1.30e-07 | 5 | 48 | 3 | GO:0031821 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 3.58e-07 | 25 | 48 | 4 | GO:0031683 | |
| GeneOntologyMolecularFunction | neuromedin U binding | 5.66e-06 | 2 | 48 | 2 | GO:0042924 | |
| GeneOntologyMolecularFunction | neuromedin U receptor activity | 5.66e-06 | 2 | 48 | 2 | GO:0001607 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 3.26e-05 | 26 | 48 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 3.26e-05 | 26 | 48 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | complement component C5a receptor activity | 3.38e-05 | 4 | 48 | 2 | GO:0004878 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.66e-05 | 165 | 48 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 8.08e-05 | 35 | 48 | 3 | GO:0033612 | |
| GeneOntologyMolecularFunction | peptide binding | 1.09e-04 | 318 | 48 | 6 | GO:0042277 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.18e-04 | 7 | 48 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | opsonin receptor activity | 1.57e-04 | 8 | 48 | 2 | GO:0001847 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 3.07e-04 | 11 | 48 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | complement receptor activity | 5.06e-04 | 14 | 48 | 2 | GO:0004875 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 7.97e-04 | 839 | 48 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 8.03e-04 | 840 | 48 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 8.03e-04 | 840 | 48 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | GTPase activating protein binding | 9.43e-04 | 19 | 48 | 2 | GO:0032794 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 1.26e-03 | 337 | 48 | 5 | GO:0001664 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 1.39e-03 | 23 | 48 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 1.51e-03 | 24 | 48 | 2 | GO:0019957 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.64e-03 | 97 | 48 | 3 | GO:0004896 | |
| GeneOntologyMolecularFunction | hormone binding | 1.95e-03 | 103 | 48 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.37e-03 | 775 | 48 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | GTP binding | 2.57e-03 | 397 | 48 | 5 | GO:0005525 | |
| GeneOntologyMolecularFunction | chemokine binding | 2.85e-03 | 33 | 48 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 3.95e-03 | 439 | 48 | 5 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 3.95e-03 | 439 | 48 | 5 | GO:0019001 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 6.94e-03 | 162 | 48 | 3 | GO:0099106 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 7.48e-03 | 54 | 48 | 2 | GO:0005246 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 7.75e-03 | 55 | 48 | 2 | GO:0017046 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 8.30e-03 | 57 | 48 | 2 | GO:0015459 | |
| GeneOntologyMolecularFunction | channel regulator activity | 8.44e-03 | 174 | 48 | 3 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 8.84e-03 | 177 | 48 | 3 | GO:0141108 | |
| GeneOntologyMolecularFunction | GTPase activity | 9.01e-03 | 341 | 48 | 4 | GO:0003924 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.40e-02 | 75 | 48 | 2 | GO:0098960 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 1.51e-02 | 78 | 48 | 2 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.59e-02 | 80 | 48 | 2 | GO:0008186 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 OR2T5 GNAI1 GNAI2 CCR7 TACR1 GNAI3 NMUR2 PTAFR GNAZ TAS2R38 OR4K15 GPRC5B OPRD1 OPRK1 | 2.70e-21 | 1395 | 47 | 28 | GO:0007186 |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 8.59e-12 | 124 | 47 | 9 | GO:0007218 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 1.62e-11 | 133 | 47 | 9 | GO:0007200 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.80e-11 | 86 | 47 | 8 | GO:0007193 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.44e-08 | 286 | 47 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | feeding behavior | 7.82e-08 | 162 | 47 | 7 | GO:0007631 | |
| GeneOntologyBiologicalProcess | eating behavior | 1.73e-07 | 56 | 47 | 5 | GO:0042755 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 2.31e-07 | 284 | 47 | 8 | GO:0007626 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 3.85e-07 | 125 | 47 | 6 | GO:0051952 | |
| GeneOntologyBiologicalProcess | behavior | GHSR NPY2R DRD4 NTSR1 RXFP4 GRID1 TACR1 NMUR2 GPRC5B OPRD1 OPRK1 OTOG | 5.07e-07 | 891 | 47 | 12 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of system process | GHSR NPY2R DRD4 NTSR1 GNAI2 TACR1 GNAI3 CAV3 NMUR2 PTAFR OPRK1 | 5.81e-07 | 734 | 47 | 11 | GO:0044057 |
| GeneOntologyBiologicalProcess | amine transport | 6.60e-07 | 137 | 47 | 6 | GO:0015837 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 7.05e-07 | 224 | 47 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 9.81e-07 | 79 | 47 | 5 | GO:0006940 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle contraction | 1.32e-06 | 36 | 47 | 4 | GO:0045987 | |
| GeneOntologyBiologicalProcess | regulation of secretion | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GNAI2 TACR1 PTAFR GNAZ OPRK1 | 1.37e-06 | 801 | 47 | 11 | GO:0051046 |
| GeneOntologyBiologicalProcess | positive regulation of behavior | 2.74e-06 | 43 | 47 | 4 | GO:0048520 | |
| GeneOntologyBiologicalProcess | positive regulation of feeding behavior | 3.12e-06 | 13 | 47 | 3 | GO:2000253 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 5.17e-06 | 740 | 47 | 10 | GO:1903530 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GRID1 GNAI1 GNAI2 TACR1 OPRK1 | 5.84e-06 | 931 | 47 | 11 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GRID1 GNAI1 GNAI2 TACR1 OPRK1 | 5.84e-06 | 931 | 47 | 11 | GO:0007268 |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 6.30e-06 | 202 | 47 | 6 | GO:0006937 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GRID1 GNAI1 GNAI2 TACR1 OPRK1 | 6.34e-06 | 939 | 47 | 11 | GO:0099537 |
| GeneOntologyBiologicalProcess | adult behavior | 6.48e-06 | 203 | 47 | 6 | GO:0030534 | |
| GeneOntologyBiologicalProcess | synaptic signaling | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GRID1 GNAI1 GNAI2 TACR1 OPRK1 | 9.14e-06 | 976 | 47 | 11 | GO:0099536 |
| GeneOntologyBiologicalProcess | positive regulation of amine transport | 9.17e-06 | 58 | 47 | 4 | GO:0051954 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle contraction | 9.82e-06 | 59 | 47 | 4 | GO:0045933 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.12e-05 | 61 | 47 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell proliferation | 1.26e-05 | 228 | 47 | 6 | GO:0048660 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.28e-05 | 133 | 47 | 5 | GO:0006939 | |
| GeneOntologyBiologicalProcess | secretion | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GNAI2 TACR1 NMUR2 PTAFR GNAZ OPRK1 | 1.33e-05 | 1221 | 47 | 12 | GO:0046903 |
| GeneOntologyBiologicalProcess | smooth muscle cell proliferation | 1.56e-05 | 237 | 47 | 6 | GO:0048659 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 1.64e-05 | 239 | 47 | 6 | GO:0051048 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | GHSR BRIP1 DRD4 GNAI1 GNAI2 CCR7 GNAI3 CAV3 PTAFR DDX21 OPRD1 OPRK1 | 2.00e-05 | 1272 | 47 | 12 | GO:1901698 |
| GeneOntologyBiologicalProcess | secretion by cell | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GNAI2 TACR1 PTAFR GNAZ OPRK1 | 2.05e-05 | 1064 | 47 | 11 | GO:0032940 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 3.00e-05 | 266 | 47 | 6 | GO:0019722 | |
| GeneOntologyBiologicalProcess | complement component C5a signaling pathway | 3.04e-05 | 4 | 47 | 2 | GO:0038178 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | 3.06e-05 | 267 | 47 | 6 | GO:0002685 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 3.30e-05 | 80 | 47 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | export from cell | GHSR NPY2R DRD4 SV2A NTSR1 SV2C GNAI2 TACR1 PTAFR GNAZ OPRK1 | 4.30e-05 | 1153 | 47 | 11 | GO:0140352 |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 4.77e-05 | 175 | 47 | 5 | GO:0031644 | |
| GeneOntologyBiologicalProcess | negative regulation of transport | 4.85e-05 | 587 | 47 | 8 | GO:0051051 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 6.74e-05 | 96 | 47 | 4 | GO:0051937 | |
| GeneOntologyBiologicalProcess | arachidonate secretion | 7.51e-05 | 36 | 47 | 3 | GO:0050482 | |
| GeneOntologyBiologicalProcess | arachidonate transport | 7.51e-05 | 36 | 47 | 3 | GO:1903963 | |
| GeneOntologyBiologicalProcess | positive regulation of eating behavior | 7.58e-05 | 6 | 47 | 2 | GO:1904000 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 7.94e-05 | 317 | 47 | 6 | GO:0090257 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 8.80e-05 | 323 | 47 | 6 | GO:0051924 | |
| GeneOntologyBiologicalProcess | muscle cell proliferation | 9.74e-05 | 329 | 47 | 6 | GO:0033002 | |
| GeneOntologyBiologicalProcess | signal release | 1.02e-04 | 653 | 47 | 8 | GO:0023061 | |
| GeneOntologyBiologicalProcess | positive regulation of gastro-intestinal system smooth muscle contraction | 1.06e-04 | 7 | 47 | 2 | GO:1904306 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil chemotaxis | 1.11e-04 | 41 | 47 | 3 | GO:0090022 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.13e-04 | 663 | 47 | 8 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.15e-04 | 664 | 47 | 8 | GO:0099177 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.17e-04 | 493 | 47 | 7 | GO:0010959 | |
| GeneOntologyBiologicalProcess | sensory perception | OR2T29 BBS7 OR4K1 NTSR1 OR2T5 NMUR2 TAS2R38 OR4K15 OPRK1 OTOG | 1.23e-04 | 1072 | 47 | 10 | GO:0007600 |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 1.23e-04 | 214 | 47 | 5 | GO:1903531 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | 1.32e-04 | 1081 | 47 | 10 | GO:0051050 | |
| GeneOntologyBiologicalProcess | G protein-coupled dopamine receptor signaling pathway | 1.38e-04 | 44 | 47 | 3 | GO:0007212 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 1.41e-04 | 116 | 47 | 4 | GO:0008344 | |
| GeneOntologyBiologicalProcess | monoamine transport | 1.41e-04 | 116 | 47 | 4 | GO:0015844 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.43e-04 | 509 | 47 | 7 | GO:0006816 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.57e-04 | 359 | 47 | 6 | GO:0006874 | |
| GeneOntologyBiologicalProcess | regulation of gastro-intestinal system smooth muscle contraction | 1.81e-04 | 9 | 47 | 2 | GO:1904304 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.93e-04 | 126 | 47 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 2.03e-04 | 722 | 47 | 8 | GO:0051606 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 2.05e-04 | 128 | 47 | 4 | GO:0050795 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CXCR3 DRD4 NTSR1 NMUR1 GRID1 GNAI2 CCR7 CAV3 NMUR2 OPRD1 OPRK1 | 2.06e-04 | 1374 | 47 | 11 | GO:0006811 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 2.42e-04 | 389 | 47 | 6 | GO:0055074 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 2.54e-04 | 559 | 47 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 2.68e-04 | 752 | 47 | 8 | GO:1901699 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell proliferation | 2.74e-04 | 138 | 47 | 4 | GO:0048661 | |
| GeneOntologyBiologicalProcess | response to ketone | 2.74e-04 | 254 | 47 | 5 | GO:1901654 | |
| GeneOntologyBiologicalProcess | positive regulation of dopamine secretion | 2.76e-04 | 11 | 47 | 2 | GO:0033603 | |
| GeneOntologyBiologicalProcess | muscle contraction | 2.81e-04 | 400 | 47 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | icosanoid secretion | 2.82e-04 | 56 | 47 | 3 | GO:0032309 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 2.87e-04 | 1190 | 47 | 10 | GO:0008284 | |
| GeneOntologyBiologicalProcess | dopamine transport | 2.98e-04 | 57 | 47 | 3 | GO:0015872 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 3.08e-04 | 577 | 47 | 7 | GO:0043269 | |
| GeneOntologyBiologicalProcess | response to nicotine | 3.13e-04 | 58 | 47 | 3 | GO:0035094 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil migration | 3.30e-04 | 59 | 47 | 3 | GO:1902622 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 3.90e-04 | 13 | 47 | 2 | GO:0038003 | |
| GeneOntologyBiologicalProcess | regulation of gamma-aminobutyric acid secretion | 3.90e-04 | 13 | 47 | 2 | GO:0014052 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 4.19e-04 | 64 | 47 | 3 | GO:1903351 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 4.23e-04 | 1249 | 47 | 10 | GO:0048878 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte chemotaxis | 4.39e-04 | 65 | 47 | 3 | GO:0071622 | |
| GeneOntologyBiologicalProcess | response to dopamine | 4.59e-04 | 66 | 47 | 3 | GO:1903350 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 4.80e-04 | 67 | 47 | 3 | GO:0050433 | |
| GeneOntologyBiologicalProcess | response to hormone | 4.97e-04 | 1042 | 47 | 9 | GO:0009725 | |
| GeneOntologyBiologicalProcess | inflammatory response | 5.01e-04 | 1043 | 47 | 9 | GO:0006954 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 5.01e-04 | 68 | 47 | 3 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 5.01e-04 | 68 | 47 | 3 | GO:0071870 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 5.18e-04 | 1048 | 47 | 9 | GO:0014070 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 5.19e-04 | 449 | 47 | 6 | GO:0050900 | |
| GeneOntologyBiologicalProcess | gastro-intestinal system smooth muscle contraction | 5.24e-04 | 15 | 47 | 2 | GO:0014831 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | 5.76e-04 | 1299 | 47 | 10 | GO:1902533 | |
| GeneOntologyBiologicalProcess | complement receptor mediated signaling pathway | 5.98e-04 | 16 | 47 | 2 | GO:0002430 | |
| GeneOntologyBiologicalProcess | positive regulation of inositol phosphate biosynthetic process | 5.98e-04 | 16 | 47 | 2 | GO:0060732 | |
| GeneOntologyBiologicalProcess | regulation of eating behavior | 5.98e-04 | 16 | 47 | 2 | GO:1903998 | |
| GeneOntologyBiologicalProcess | blood circulation | 6.17e-04 | 648 | 47 | 7 | GO:0008015 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 1.22e-06 | 35 | 48 | 4 | GO:0005834 | |
| GeneOntologyCellularComponent | GTPase complex | 2.33e-06 | 41 | 48 | 4 | GO:1905360 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 8.23e-06 | 56 | 48 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 6.47e-05 | 185 | 48 | 5 | GO:0009898 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.80e-04 | 230 | 48 | 5 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.75e-04 | 137 | 48 | 4 | GO:0019897 | |
| GeneOntologyCellularComponent | dendrite | 6.84e-04 | 858 | 48 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 6.95e-04 | 860 | 48 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 7.54e-04 | 179 | 48 | 4 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 7.54e-04 | 179 | 48 | 4 | GO:0030672 | |
| GeneOntologyCellularComponent | axon terminus | 1.36e-03 | 210 | 48 | 4 | GO:0043679 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.90e-03 | 230 | 48 | 4 | GO:0019898 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.99e-03 | 233 | 48 | 4 | GO:0044306 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 3.09e-03 | 36 | 48 | 2 | GO:0098992 | |
| GeneOntologyCellularComponent | side of membrane | 3.62e-03 | 875 | 48 | 7 | GO:0098552 | |
| GeneOntologyCellularComponent | lysosomal membrane | 4.04e-03 | 462 | 48 | 5 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 4.04e-03 | 462 | 48 | 5 | GO:0098852 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 4.53e-03 | 293 | 48 | 4 | GO:0030658 | |
| GeneOntologyCellularComponent | synaptic vesicle | 4.93e-03 | 300 | 48 | 4 | GO:0008021 | |
| GeneOntologyCellularComponent | cell body | 5.02e-03 | 929 | 48 | 7 | GO:0044297 | |
| GeneOntologyCellularComponent | vacuolar membrane | 5.97e-03 | 507 | 48 | 5 | GO:0005774 | |
| GeneOntologyCellularComponent | exocytic vesicle | 6.18e-03 | 320 | 48 | 4 | GO:0070382 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 6.33e-03 | 164 | 48 | 3 | GO:0098982 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 6.41e-03 | 1228 | 48 | 8 | GO:0036477 | |
| GeneOntologyCellularComponent | secretory vesicle | 6.98e-03 | 1246 | 48 | 8 | GO:0099503 | |
| GeneOntologyCellularComponent | dense core granule | 7.35e-03 | 56 | 48 | 2 | GO:0031045 | |
| MousePheno | abnormal chemically-elicited antinociception | 1.43e-06 | 29 | 41 | 4 | MP:0001980 | |
| MousePheno | impaired behavioral response to addictive substance | 8.70e-06 | 45 | 41 | 4 | MP:0009750 | |
| MousePheno | abnormal behavioral response to addictive substance | 1.14e-05 | 102 | 41 | 5 | MP:0009748 | |
| MousePheno | decreased chemically-elicited antinociception | 2.20e-05 | 19 | 41 | 3 | MP:0001982 | |
| MousePheno | impaired behavioral response to xenobiotic | 9.90e-05 | 83 | 41 | 4 | MP:0009747 | |
| MousePheno | abnormal pain threshold | 1.18e-04 | 267 | 41 | 6 | MP:0001970 | |
| MousePheno | abnormal response/metabolism to endogenous compounds | 2.37e-04 | 104 | 41 | 4 | MP:0003638 | |
| MousePheno | abnormal behavioral response to xenobiotic | 2.60e-04 | 309 | 41 | 6 | MP:0009745 | |
| MousePheno | impaired behavioral response to morphine | 3.72e-04 | 10 | 41 | 2 | MP:0009757 | |
| Domain | GPCR_Rhodpsn_7TM | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 OR2T5 CCR7 TACR1 NMUR2 PTAFR OR4K15 OPRD1 OPRK1 | 1.30e-19 | 670 | 48 | 22 | IPR017452 |
| Domain | 7tm_1 | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 OR2T5 CCR7 TACR1 NMUR2 PTAFR OR4K15 OPRD1 OPRK1 | 1.63e-19 | 677 | 48 | 22 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 OR2T5 CCR7 TACR1 NMUR2 PTAFR OR4K15 OPRD1 OPRK1 | 2.09e-19 | 685 | 48 | 22 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 OR2T5 CCR7 TACR1 NMUR2 PTAFR OR4K15 OPRD1 OPRK1 | 2.52e-19 | 691 | 48 | 22 | PS50262 |
| Domain | GPCR_Rhodpsn | GHSR CMKLR2 QRFPR OR2T29 CXCR3 NPY2R DRD4 GPR17 OR4K1 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 OR2T5 CCR7 TACR1 NMUR2 PTAFR OR4K15 OPRD1 OPRK1 | 2.60e-19 | 692 | 48 | 22 | IPR000276 |
| Domain | Gprotein_alpha_I | 2.67e-09 | 8 | 48 | 4 | IPR001408 | |
| Domain | G-alpha | 6.83e-08 | 16 | 48 | 4 | PF00503 | |
| Domain | GproteinA_insert | 6.83e-08 | 16 | 48 | 4 | IPR011025 | |
| Domain | G_alpha | 6.83e-08 | 16 | 48 | 4 | SM00275 | |
| Domain | - | 6.83e-08 | 16 | 48 | 4 | 1.10.400.10 | |
| Domain | Gprotein_alpha_su | 8.92e-08 | 17 | 48 | 4 | IPR001019 | |
| Domain | 7TM_GPCR_Srsx | 4.06e-07 | 112 | 48 | 6 | SM01381 | |
| Domain | NeuromedU_rcpt | 6.47e-06 | 2 | 48 | 2 | IPR005390 | |
| Domain | Pentapeptide_4 | 1.94e-05 | 3 | 48 | 2 | PF13599 | |
| Domain | SV2 | 1.94e-05 | 3 | 48 | 2 | IPR022308 | |
| Domain | Opioid_rcpt | 3.87e-05 | 4 | 48 | 2 | IPR001418 | |
| Domain | 5peptide_repeat | 3.87e-05 | 4 | 48 | 2 | IPR001646 | |
| Domain | NPY_rcpt | 2.30e-04 | 9 | 48 | 2 | IPR000611 | |
| Domain | Formyl_rcpt-rel | 2.87e-04 | 10 | 48 | 2 | IPR000826 | |
| Domain | Chemokine_rcpt | 7.58e-04 | 16 | 48 | 2 | IPR000355 | |
| Domain | - | 2.79e-03 | 746 | 48 | 7 | 3.40.50.300 | |
| Domain | Sugar_transporter_CS | 3.05e-03 | 32 | 48 | 2 | IPR005829 | |
| Domain | Sugar_tr | 3.85e-03 | 36 | 48 | 2 | PF00083 | |
| Domain | MFS_sugar_transport-like | 3.85e-03 | 36 | 48 | 2 | IPR005828 | |
| Domain | P-loop_NTPase | 5.63e-03 | 848 | 48 | 7 | IPR027417 | |
| Domain | MFS | 1.67e-02 | 77 | 48 | 2 | IPR011701 | |
| Domain | MFS_1 | 1.67e-02 | 77 | 48 | 2 | PF07690 | |
| Domain | Olfact_rcpt | 1.81e-02 | 393 | 48 | 4 | IPR000725 | |
| Pathway | WP_GPCRS_NONODORANT | GHSR QRFPR CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 CCR7 TACR1 NMUR2 PTAFR GPRC5B OPRD1 OPRK1 | 1.22e-20 | 266 | 42 | 18 | MM15843 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GHSR QRFPR CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 GNAI1 GNAI2 CCR7 TACR1 GNAI3 NMUR2 PTAFR GNAZ TAS2R38 OPRD1 OPRK1 | 5.36e-19 | 646 | 42 | 22 | MM14962 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GHSR QRFPR CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 GNAI1 GNAI2 CCR7 TACR1 GNAI3 NMUR2 PTAFR GNAZ TAS2R38 OPRD1 OPRK1 | 3.17e-18 | 702 | 42 | 22 | M746 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | GHSR QRFPR CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 CCR7 TACR1 NMUR2 PTAFR OPRD1 OPRK1 | 1.89e-17 | 330 | 42 | 17 | M18334 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GHSR QRFPR CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 CCR7 TACR1 NMUR2 PTAFR TAS2R38 OPRD1 OPRK1 | 2.44e-16 | 463 | 42 | 18 | M507 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | CXCR3 NPY2R DRD4 GPR17 NMUR1 RXFP4 C3AR1 GNAI1 GNAI2 CCR7 GNAI3 NMUR2 GNAZ TAS2R38 OPRD1 OPRK1 | 2.48e-16 | 314 | 42 | 16 | M600 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | GHSR QRFPR CXCR3 NPY2R NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 CCR7 TACR1 NMUR2 OPRD1 OPRK1 | 2.55e-16 | 197 | 42 | 14 | M12289 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GHSR CMKLR2 CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 C3AR1 CCR7 NMUR2 PTAFR OPRD1 OPRK1 | 4.11e-16 | 260 | 42 | 15 | M39397 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | QRFPR CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 CCR7 TACR1 NMUR2 PTAFR OPRD1 OPRK1 | 6.27e-16 | 333 | 42 | 16 | MM14963 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | QRFPR CXCR3 NPY2R DRD4 GPR17 NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 CCR7 TACR1 NMUR2 PTAFR TAS2R38 OPRD1 OPRK1 | 1.58e-15 | 430 | 42 | 17 | MM15160 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | CXCR3 NPY2R DRD4 GPR17 NMUR1 RXFP4 C3AR1 GNAI1 GNAI2 CCR7 GNAI3 NMUR2 TAS2R38 OPRD1 OPRK1 | 1.98e-15 | 289 | 42 | 15 | MM15057 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | QRFPR CXCR3 NPY2R NTSR1 C5AR2 NMUR1 RXFP4 C3AR1 CCR7 TACR1 NMUR2 OPRD1 OPRK1 | 9.32e-15 | 197 | 42 | 13 | MM14970 |
| Pathway | WP_GPCRS_PEPTIDE | 4.22e-13 | 70 | 42 | 9 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 8.06e-13 | 75 | 42 | 9 | M39696 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GHSR NPY2R DRD4 NTSR1 NMUR1 GRID1 C3AR1 TACR1 NMUR2 PTAFR OPRD1 OPRK1 | 1.38e-11 | 272 | 42 | 12 | M13380 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.06e-09 | 186 | 42 | 9 | MM15994 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 6.67e-08 | 14 | 42 | 4 | M64 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.62e-07 | 210 | 42 | 8 | MM15043 | |
| Pathway | PID_CXCR3_PATHWAY | 1.63e-07 | 43 | 42 | 5 | M222 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.09e-07 | 217 | 42 | 8 | M18437 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 3.93e-07 | 21 | 42 | 4 | M103 | |
| Pathway | PID_S1P_META_PATHWAY | 3.93e-07 | 21 | 42 | 4 | M155 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 6.93e-07 | 24 | 42 | 4 | M268 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.36e-06 | 8 | 42 | 3 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 1.36e-06 | 8 | 42 | 3 | M47643 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 1.53e-06 | 29 | 42 | 4 | M55 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 2.02e-06 | 31 | 42 | 4 | M213 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.04e-06 | 9 | 42 | 3 | M47641 | |
| Pathway | WP_PURINERGIC_SIGNALING | 2.62e-06 | 33 | 42 | 4 | M39855 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 3.99e-06 | 11 | 42 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 5.31e-06 | 12 | 42 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 5.31e-06 | 12 | 42 | 3 | M47559 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 5.75e-06 | 40 | 42 | 4 | M41 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 7.72e-06 | 43 | 42 | 4 | M29837 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 7.72e-06 | 43 | 42 | 4 | M238 | |
| Pathway | WP_GPCRS_OTHER | 7.86e-06 | 93 | 42 | 5 | M39629 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 8.75e-06 | 14 | 42 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 8.75e-06 | 14 | 42 | 3 | M750 | |
| Pathway | REACTOME_GPER1_SIGNALING | 9.28e-06 | 45 | 42 | 4 | M45008 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.20e-05 | 48 | 42 | 4 | M219 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.20e-05 | 48 | 42 | 4 | M10775 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.62e-05 | 17 | 42 | 3 | M47544 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 3.57e-05 | 63 | 42 | 4 | M8 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 3.64e-05 | 22 | 42 | 3 | M841 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 3.64e-05 | 22 | 42 | 3 | MM15016 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 4.04e-05 | 65 | 42 | 4 | M15 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 4.18e-05 | 23 | 42 | 3 | MM15952 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 5.40e-05 | 25 | 42 | 3 | M39384 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 5.41e-05 | 70 | 42 | 4 | M8232 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 6.10e-05 | 26 | 42 | 3 | M47553 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 6.84e-05 | 27 | 42 | 3 | M47519 | |
| Pathway | REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD | 8.62e-05 | 5 | 42 | 2 | M27427 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 1.24e-04 | 165 | 42 | 5 | M39400 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 1.26e-04 | 33 | 42 | 3 | MM15020 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 1.26e-04 | 33 | 42 | 3 | M9379 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.44e-04 | 90 | 42 | 4 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.51e-04 | 91 | 42 | 4 | M39426 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 1.78e-04 | 37 | 42 | 3 | M42558 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.85e-04 | 96 | 42 | 4 | M39581 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 2.06e-04 | 184 | 42 | 5 | MM15943 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.09e-04 | 39 | 42 | 3 | MM14496 | |
| Pathway | PID_CXCR4_PATHWAY | 2.17e-04 | 100 | 42 | 4 | M124 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 2.28e-04 | 188 | 42 | 5 | M4844 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.79e-04 | 43 | 42 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.99e-04 | 44 | 42 | 3 | MM15709 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 3.83e-04 | 116 | 42 | 4 | M2164 | |
| Pathway | REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS | 3.84e-04 | 10 | 42 | 2 | M27018 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 4.37e-04 | 50 | 42 | 3 | M47951 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 4.60e-04 | 219 | 42 | 5 | M29836 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 5.49e-04 | 54 | 42 | 3 | M26911 | |
| Pathway | KEGG_TIGHT_JUNCTION | 6.24e-04 | 132 | 42 | 4 | M11355 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 6.60e-04 | 134 | 42 | 4 | M29840 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 7.48e-04 | 60 | 42 | 3 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 7.48e-04 | 60 | 42 | 3 | MM15708 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 9.34e-04 | 147 | 42 | 4 | MM15854 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 9.88e-04 | 66 | 42 | 3 | M39684 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.03e-03 | 151 | 42 | 4 | M39329 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.19e-03 | 157 | 42 | 4 | M4904 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.22e-03 | 71 | 42 | 3 | MM14491 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.22e-03 | 71 | 42 | 3 | MM15590 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.43e-03 | 75 | 42 | 3 | M27874 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 1.76e-03 | 21 | 42 | 2 | M39343 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.05e-03 | 85 | 42 | 3 | M3578 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 2.05e-03 | 85 | 42 | 3 | M48315 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 2.11e-03 | 23 | 42 | 2 | MM15033 | |
| Pathway | KEGG_GAP_JUNCTION | 2.41e-03 | 90 | 42 | 3 | M4013 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.41e-03 | 90 | 42 | 3 | M6467 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 2.57e-03 | 92 | 42 | 3 | M39441 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 2.69e-03 | 26 | 42 | 2 | M4047 | |
| Pathway | WP_GPCRS_OTHER | 2.90e-03 | 96 | 42 | 3 | MM15939 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 3.12e-03 | 28 | 42 | 2 | M10679 | |
| Pathway | WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION | 3.34e-03 | 29 | 42 | 2 | M39797 | |
| Pathway | REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS | 3.34e-03 | 29 | 42 | 2 | M27431 | |
| Pathway | KEGG_MELANOGENESIS | 3.35e-03 | 101 | 42 | 3 | M7761 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 4.06e-03 | 32 | 42 | 2 | MM1492 | |
| Pathway | WP_5Q35_COPY_NUMBER_VARIATION | 4.36e-03 | 111 | 42 | 3 | M48089 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 4.84e-03 | 35 | 42 | 2 | M127 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 6.60e-03 | 41 | 42 | 2 | M39655 | |
| Pathway | KEGG_AXON_GUIDANCE | 6.62e-03 | 129 | 42 | 3 | M5539 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 7.21e-03 | 133 | 42 | 3 | MM15529 | |
| Pubmed | NPY2R DRD4 NTSR1 NMUR1 RXFP4 C3AR1 GNAI1 GNAI2 CCR7 GNAI3 NMUR2 PTAFR OPRD1 OPRK1 | 3.15e-21 | 179 | 49 | 14 | 18577758 | |
| Pubmed | 8.95e-18 | 75 | 49 | 10 | 2834384 | ||
| Pubmed | 9.66e-12 | 200 | 49 | 9 | 18240029 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 8986788 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 1.81e-10 | 182 | 49 | 8 | 20468064 | |
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 7.25e-10 | 10 | 49 | 4 | 8521505 | |
| Pubmed | Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse. | 1.71e-09 | 12 | 49 | 4 | 2508088 | |
| Pubmed | Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. | 2.46e-09 | 13 | 49 | 4 | 8208289 | |
| Pubmed | Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. | 2.46e-09 | 13 | 49 | 4 | 16892066 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 16962188 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 15788486 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 17484771 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 29342363 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 30836096 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 4.50e-09 | 95 | 49 | 6 | 16754659 | |
| Pubmed | 4.69e-09 | 15 | 49 | 4 | 11118617 | ||
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 1.05e-08 | 4 | 49 | 3 | 11248120 | |
| Pubmed | The neuropeptide neuromedin U promotes autoantibody-mediated arthritis. | 1.05e-08 | 4 | 49 | 3 | 22314006 | |
| Pubmed | RGS10 is a selective activator of G alpha i GTPase activity. | 1.05e-08 | 4 | 49 | 3 | 8774883 | |
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 17635935 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 20508603 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 11771389 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 12297509 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 11168387 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 12379657 | ||
| Pubmed | Guanine nucleotide-binding regulatory proteins in retinal pigment epithelial cells. | 1.05e-08 | 4 | 49 | 3 | 1902575 | |
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 1.05e-08 | 4 | 49 | 3 | 18832081 | |
| Pubmed | Analysis of RGSZ1 protein interaction with Galphai subunits. | 1.05e-08 | 4 | 49 | 3 | 15488169 | |
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 21931697 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 28145731 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 12860983 | ||
| Pubmed | Coupling of dopamine receptor subtypes to multiple and diverse G proteins. | 2.62e-08 | 5 | 49 | 3 | 10978845 | |
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 26373672 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 16298104 | ||
| Pubmed | Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. | 2.62e-08 | 5 | 49 | 3 | 22706085 | |
| Pubmed | Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. | 2.62e-08 | 5 | 49 | 3 | 2820999 | |
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 22230296 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 11387333 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 24415754 | ||
| Pubmed | 3.62e-08 | 24 | 49 | 4 | 2902634 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 25078664 | ||
| Pubmed | Identification of the platelet ADP receptor targeted by antithrombotic drugs. | 5.24e-08 | 6 | 49 | 3 | 11196645 | |
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 16371464 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 23236180 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 19401591 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 30975754 | ||
| Pubmed | The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein. | 5.24e-08 | 6 | 49 | 3 | 9647645 | |
| Pubmed | Cloning and characterization of a novel regulator of G protein signalling in human platelets. | 5.24e-08 | 6 | 49 | 3 | 11955952 | |
| Pubmed | Characterization of RGS5 in regulation of G protein-coupled receptor signaling. | 5.24e-08 | 6 | 49 | 3 | 11253162 | |
| Pubmed | 6.94e-08 | 28 | 49 | 4 | 8858601 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 15251452 | ||
| Pubmed | Activation state-dependent interaction between Galphai and p67phox. | 9.16e-08 | 7 | 49 | 3 | 16782902 | |
| Pubmed | 1.06e-07 | 81 | 49 | 5 | 22723691 | ||
| Pubmed | The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets. | 1.46e-07 | 8 | 49 | 3 | 34099640 | |
| Pubmed | Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. | 1.46e-07 | 8 | 49 | 3 | 12509430 | |
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 2.19e-07 | 9 | 49 | 3 | 38651641 | |
| Pubmed | 3.13e-07 | 10 | 49 | 3 | 26755700 | ||
| Pubmed | 3.13e-07 | 10 | 49 | 3 | 8552586 | ||
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 5.73e-07 | 12 | 49 | 3 | 9611134 | |
| Pubmed | RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao. | 5.73e-07 | 12 | 49 | 3 | 10926822 | |
| Pubmed | Evolution of the mammalian G protein alpha subunit multigene family. | 7.03e-07 | 49 | 49 | 4 | 1302014 | |
| Pubmed | 7.44e-07 | 13 | 49 | 3 | 23637329 | ||
| Pubmed | A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells. | 7.44e-07 | 13 | 49 | 3 | 24135232 | |
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 9.46e-07 | 14 | 49 | 3 | 14993377 | |
| Pubmed | 9.46e-07 | 14 | 49 | 3 | 15972662 | ||
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.05e-06 | 128 | 49 | 5 | 19058789 | |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 1.13e-06 | 130 | 49 | 5 | 19874574 | |
| Pubmed | 1.18e-06 | 15 | 49 | 3 | 24478091 | ||
| Pubmed | Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. | 1.76e-06 | 17 | 49 | 3 | 18453587 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16331961 | ||
| Pubmed | Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice. | 1.94e-06 | 2 | 49 | 2 | 25944935 | |
| Pubmed | Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling. | 1.94e-06 | 2 | 49 | 2 | 17289675 | |
| Pubmed | Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils. | 1.94e-06 | 2 | 49 | 2 | 26976957 | |
| Pubmed | Identification of kappa- and delta-opioid receptor transcripts in immune cells. | 1.94e-06 | 2 | 49 | 2 | 7649271 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17379411 | ||
| Pubmed | Feeling at home: Structure of the NTSR1-Gi complex in a lipid environment. | 1.94e-06 | 2 | 49 | 2 | 33785921 | |
| Pubmed | Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. | 1.94e-06 | 2 | 49 | 2 | 24923251 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22039261 | ||
| Pubmed | Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. | 1.94e-06 | 2 | 49 | 2 | 8393575 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24278116 | ||
| Pubmed | Conformational transitions of a neurotensin receptor 1-Gi1 complex. | 1.94e-06 | 2 | 49 | 2 | 31243364 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11073886 | ||
| Pubmed | Gαi2- and Gαi3-deficient mice display opposite severity of myocardial ischemia reperfusion injury. | 1.94e-06 | 2 | 49 | 2 | 24858945 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18497951 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11316510 | ||
| Pubmed | G-protein-coupled receptor heterodimerization modulates receptor function. | 1.94e-06 | 2 | 49 | 2 | 10385123 | |
| Pubmed | Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease. | 1.94e-06 | 2 | 49 | 2 | 18521956 | |
| Pubmed | The human genome encodes at least three non-allellic G proteins with alpha i-type subunits. | 1.94e-06 | 2 | 49 | 2 | 2440724 | |
| Pubmed | FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus. | 1.94e-06 | 2 | 49 | 2 | 21788441 | |
| Pubmed | A small multigene family encodes Gi signal-transduction proteins. | 1.94e-06 | 2 | 49 | 2 | 3120178 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 31974445 | ||
| Pubmed | Targeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivity. | 1.94e-06 | 2 | 49 | 2 | 11158953 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17622222 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25049334 | ||
| Pubmed | Gαi2 is the essential Gαi protein in immune complex-induced lung disease. | 1.94e-06 | 2 | 49 | 2 | 23225882 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19324999 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16977602 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25225330 | ||
| Pubmed | Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells. | 1.94e-06 | 2 | 49 | 2 | 22308501 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16712978 | ||
| Interaction | ADCK1 interactions | 2.47e-08 | 79 | 46 | 6 | int:ADCK1 | |
| Interaction | OPRD1 interactions | 1.08e-07 | 51 | 46 | 5 | int:OPRD1 | |
| Interaction | LMBRD2 interactions | 3.69e-07 | 65 | 46 | 5 | int:LMBRD2 | |
| Interaction | NCF2 interactions | 8.15e-07 | 32 | 46 | 4 | int:NCF2 | |
| Interaction | ADRB2 interactions | 8.83e-07 | 339 | 46 | 8 | int:ADRB2 | |
| Interaction | RGS18 interactions | 9.26e-07 | 9 | 46 | 3 | int:RGS18 | |
| Interaction | RGS19 interactions | 1.48e-06 | 37 | 46 | 4 | int:RGS19 | |
| Interaction | RGS5 interactions | 2.41e-06 | 12 | 46 | 3 | int:RGS5 | |
| Interaction | GNAI1 interactions | 2.42e-06 | 171 | 46 | 6 | int:GNAI1 | |
| Interaction | GNG10 interactions | 2.75e-06 | 43 | 46 | 4 | int:GNG10 | |
| Interaction | SIMC1 interactions | 3.02e-06 | 44 | 46 | 4 | int:SIMC1 | |
| Interaction | RGS12 interactions | 3.30e-06 | 45 | 46 | 4 | int:RGS12 | |
| Interaction | ATP12A interactions | 3.58e-06 | 183 | 46 | 6 | int:ATP12A | |
| Interaction | SIGMAR1 interactions | 6.86e-06 | 117 | 46 | 5 | int:SIGMAR1 | |
| Interaction | RGS16 interactions | 7.40e-06 | 17 | 46 | 3 | int:RGS16 | |
| Interaction | CNR1 interactions | 8.87e-06 | 18 | 46 | 3 | int:CNR1 | |
| Interaction | GNG7 interactions | 1.23e-05 | 20 | 46 | 3 | int:GNG7 | |
| Interaction | PCP2 interactions | 1.44e-05 | 21 | 46 | 3 | int:PCP2 | |
| Interaction | RGS10 interactions | 1.44e-05 | 21 | 46 | 3 | int:RGS10 | |
| Interaction | RGS4 interactions | 1.66e-05 | 22 | 46 | 3 | int:RGS4 | |
| Interaction | ATP1A3 interactions | 1.98e-05 | 247 | 46 | 6 | int:ATP1A3 | |
| Interaction | GNG3 interactions | 2.18e-05 | 24 | 46 | 3 | int:GNG3 | |
| Interaction | SLC25A17 interactions | 2.18e-05 | 72 | 46 | 4 | int:SLC25A17 | |
| Interaction | GNG4 interactions | 2.47e-05 | 25 | 46 | 3 | int:GNG4 | |
| Interaction | RGS7 interactions | 2.47e-05 | 25 | 46 | 3 | int:RGS7 | |
| Interaction | CMKLR2 interactions | 3.05e-05 | 4 | 46 | 2 | int:CMKLR2 | |
| Interaction | LPCAT3 interactions | 3.31e-05 | 80 | 46 | 4 | int:LPCAT3 | |
| Interaction | GPSM2 interactions | 4.78e-05 | 31 | 46 | 3 | int:GPSM2 | |
| Interaction | RIC8A interactions | 6.77e-05 | 96 | 46 | 4 | int:RIC8A | |
| Interaction | TSPAN3 interactions | 8.25e-05 | 101 | 46 | 4 | int:TSPAN3 | |
| Interaction | NUCB1 interactions | 9.24e-05 | 104 | 46 | 4 | int:NUCB1 | |
| Interaction | NDUFB3 interactions | 1.11e-04 | 109 | 46 | 4 | int:NDUFB3 | |
| Interaction | PRRT2 interactions | 1.41e-04 | 220 | 46 | 5 | int:PRRT2 | |
| Interaction | PIK3R4 interactions | 1.51e-04 | 118 | 46 | 4 | int:PIK3R4 | |
| Interaction | RGS20 interactions | 1.51e-04 | 118 | 46 | 4 | int:RGS20 | |
| Interaction | GPR89A interactions | 1.61e-04 | 120 | 46 | 4 | int:GPR89A | |
| Interaction | CCR5 interactions | 1.91e-04 | 49 | 46 | 3 | int:CCR5 | |
| Interaction | GJA4 interactions | 2.27e-04 | 10 | 46 | 2 | int:GJA4 | |
| Interaction | GNAO1 interactions | 2.32e-04 | 132 | 46 | 4 | int:GNAO1 | |
| Interaction | SLC12A9 interactions | 2.41e-04 | 53 | 46 | 3 | int:SLC12A9 | |
| Interaction | GNB3 interactions | 2.54e-04 | 54 | 46 | 3 | int:GNB3 | |
| Interaction | SSTR3 interactions | 2.56e-04 | 393 | 46 | 6 | int:SSTR3 | |
| Interaction | GPR50 interactions | 3.14e-04 | 58 | 46 | 3 | int:GPR50 | |
| Interaction | ABHD17B interactions | 3.31e-04 | 59 | 46 | 3 | int:ABHD17B | |
| Interaction | GNA13 interactions | 3.59e-04 | 148 | 46 | 4 | int:GNA13 | |
| Interaction | ELOVL2 interactions | 3.65e-04 | 61 | 46 | 3 | int:ELOVL2 | |
| Interaction | EVI5L interactions | 3.83e-04 | 62 | 46 | 3 | int:EVI5L | |
| Interaction | MT-CO1 interactions | 3.83e-04 | 62 | 46 | 3 | int:MT-CO1 | |
| Interaction | MT-ND5 interactions | 4.40e-04 | 65 | 46 | 3 | int:MT-ND5 | |
| Interaction | OPRK1 interactions | 4.56e-04 | 14 | 46 | 2 | int:OPRK1 | |
| Interaction | GPRASP1 interactions | 4.81e-04 | 67 | 46 | 3 | int:GPRASP1 | |
| Interaction | GJA8 interactions | 4.82e-04 | 160 | 46 | 4 | int:GJA8 | |
| Interaction | GNB5 interactions | 5.03e-04 | 68 | 46 | 3 | int:GNB5 | |
| Interaction | SLC19A2 interactions | 5.25e-04 | 69 | 46 | 3 | int:SLC19A2 | |
| Interaction | ADRA2A interactions | 5.25e-04 | 15 | 46 | 2 | int:ADRA2A | |
| Interaction | GNG2 interactions | 6.19e-04 | 73 | 46 | 3 | int:GNG2 | |
| Interaction | AGTR2 interactions | 6.78e-04 | 17 | 46 | 2 | int:AGTR2 | |
| Interaction | GNG11 interactions | 6.78e-04 | 17 | 46 | 2 | int:GNG11 | |
| Interaction | LMBR1 interactions | 7.51e-04 | 78 | 46 | 3 | int:LMBR1 | |
| Interaction | GNG5 interactions | 8.09e-04 | 80 | 46 | 3 | int:GNG5 | |
| Interaction | YIPF3 interactions | 8.47e-04 | 186 | 46 | 4 | int:YIPF3 | |
| Interaction | HACD2 interactions | 8.69e-04 | 82 | 46 | 3 | int:HACD2 | |
| Interaction | EXOC6 interactions | 9.00e-04 | 83 | 46 | 3 | int:EXOC6 | |
| Interaction | GPSM3 interactions | 9.32e-04 | 84 | 46 | 3 | int:GPSM3 | |
| Interaction | FADS1 interactions | 1.03e-03 | 87 | 46 | 3 | int:FADS1 | |
| Interaction | ADORA1 interactions | 1.04e-03 | 21 | 46 | 2 | int:ADORA1 | |
| Interaction | TSHR interactions | 1.37e-03 | 96 | 46 | 3 | int:TSHR | |
| Interaction | ENDOD1 interactions | 1.37e-03 | 96 | 46 | 3 | int:ENDOD1 | |
| Cytoband | 4q27 | 2.44e-04 | 22 | 48 | 2 | 4q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q27 | 5.20e-04 | 32 | 48 | 2 | chr4q27 | |
| GeneFamily | Neuromedin U receptors | 3.43e-06 | 2 | 34 | 2 | 239 | |
| GeneFamily | Complement component GPCRs|Complement system | 1.03e-05 | 3 | 34 | 2 | 196 | |
| GeneFamily | Opioid receptors | 2.05e-05 | 4 | 34 | 2 | 245 | |
| GeneFamily | Peptide receptors | 7.17e-05 | 7 | 34 | 2 | 220 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 9.43e-03 | 78 | 34 | 2 | 262 | |
| GeneFamily | Olfactory receptors, family 2 | 1.91e-02 | 113 | 34 | 2 | 149 | |
| GeneFamily | Olfactory receptors, family 4 | 2.44e-02 | 129 | 34 | 2 | 151 | |
| Coexpression | HALLMARK_INFLAMMATORY_RESPONSE | 4.81e-08 | 200 | 45 | 7 | M5932 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 6.17e-05 | 591 | 45 | 7 | M2019 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 6.85e-05 | 601 | 45 | 7 | MM866 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS | 7.35e-05 | 130 | 45 | 4 | M40147 | |
| ToppCell | Neuronal_cells-Schwann_cells|World / Lineage and Cell class | 2.04e-06 | 189 | 49 | 5 | 371cdc92549269e45c23c5a5b3cae9c5d35ee217 | |
| ToppCell | Neuronal_cells|World / Lineage and Cell class | 2.04e-06 | 189 | 49 | 5 | 3948775a0ebd4b32c1623d5487f5581e6e2934d7 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.69e-06 | 118 | 49 | 4 | 54930a3faa055bda4a707b93d790b2ac5a360211 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.69e-06 | 118 | 49 | 4 | 18f9c1759df9504962612ec741638ed330c33222 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.69e-06 | 118 | 49 | 4 | 97db1193ecc885f63840663ab969468ce21cba74 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.69e-06 | 118 | 49 | 4 | 0c2fe46dd66e0c9cdf8c2eb66874aca79592248a | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.69e-06 | 118 | 49 | 4 | 3f8d11e09a7660af9eca5249ad698d9b638d39dd | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.52e-05 | 136 | 49 | 4 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | Hippocampus-Hematopoietic|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.30e-05 | 151 | 49 | 4 | 81b2189afd72658f7e2539b856ba79cd49340215 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.30e-05 | 151 | 49 | 4 | 2f9b3e14c2fa6e2b1976ca6ab2031b63bf5e3e64 | |
| ToppCell | Striatum-Hematopoietic|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.54e-05 | 155 | 49 | 4 | 12301d823338bf829475905c66c5f08f7159d29f | |
| ToppCell | Substantia_nigra-Hematopoietic|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.88e-05 | 160 | 49 | 4 | 19d71d02f06f34eff37d268a78e5eed34da4ca44 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.33e-05 | 166 | 49 | 4 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-05 | 167 | 49 | 4 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.82e-05 | 172 | 49 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.82e-05 | 172 | 49 | 4 | 48d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-05 | 173 | 49 | 4 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-05 | 178 | 49 | 4 | b7d1d8f76c1c2467b1a39a9b4150ed4a47144a15 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 186 | 49 | 4 | 73185d48c874e18dd2e2eeea67c32d3182ea88a5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.40e-05 | 188 | 49 | 4 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.51e-05 | 189 | 49 | 4 | 35380ca9409206e82528bde4f3795057b015278a | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.51e-05 | 189 | 49 | 4 | 31c8bc506ad69f2ed5676bd7e5319bad1075c8d8 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.74e-05 | 191 | 49 | 4 | 79c83a710aa17fc06f286e4ea2011ed9e30e3bc6 | |
| ToppCell | 11.5-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 5.86e-05 | 192 | 49 | 4 | a77d3692ff02ef7e066a9bd9e22725055a25c4d4 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 6.10e-05 | 194 | 49 | 4 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 6.10e-05 | 194 | 49 | 4 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.35e-05 | 196 | 49 | 4 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.47e-05 | 197 | 49 | 4 | 555ea43eccc3eb22be230c27e13d8b3b64c2a61f | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 7.27e-05 | 203 | 49 | 4 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.45e-05 | 74 | 49 | 3 | 06760e7179980685beddaaf7b14f4f9f932fe79c | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 90 | 49 | 3 | a0baaf2b3cf07d457f0d242fc213689cba6fd449 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 90 | 49 | 3 | ab4b08c6ac8695b38f841c0ecf2bb2c032111d04 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 94 | 49 | 3 | 82e9178c848468497295c4cc59c662b9279208a1 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 94 | 49 | 3 | be1dcfe287f58d608ccdb47cf9c1d12b5e3aa60d | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 94 | 49 | 3 | 576c37fa53fab679f5e8786f5c798e18998186e9 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 98 | 49 | 3 | fcb9da8b676f57facfdfc0ccaca585acaa6396f2 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 98 | 49 | 3 | dd6e81120ff27961da766f47a251688ee8390b90 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 98 | 49 | 3 | 8ff05867d623fa13c361789fe76634ce1f4a9354 | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 98 | 49 | 3 | 0a4198a806cf9a143d546555f5e0bef2f2b6fd6e | |
| ToppCell | Globus_pallidus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.72e-04 | 98 | 49 | 3 | 7e24ebfe74d1bd6af78b0b9d7c10852d49f85cf9 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.93e-04 | 102 | 49 | 3 | 57ad3d48adeb41f6ab65883e61d3b1e74a94ad1a | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.93e-04 | 102 | 49 | 3 | 0ec549ee94da5f2d7275490e90d816c645f6d4fc | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.93e-04 | 102 | 49 | 3 | 30fa92383898f370dabc41dd23d6907f14ba1a06 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.93e-04 | 102 | 49 | 3 | c58e09aaa11b664c7d99e91f903561fa18460f05 | |
| ToppCell | Posterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.93e-04 | 102 | 49 | 3 | 9392288e284b71f3a208d9f283e6e3c944b7dd10 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | d5f183263cec9922d23cfd38ce9157eef4e58edb | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | 1df80af2c690dac6bfd3dfd7d0052b66c1ae6ea5 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | 177414e4c859b047a4644664c596a3c22199cdf2 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | 4b5f545dc02364c5d96a02b0acd68faf1ec4192b | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 113 | 49 | 3 | 927d1071f0719b778f0c3d358c5f96a6ffac6645 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-04 | 116 | 49 | 3 | e93dd059d272e597a30e93f4c0504636f4e6c899 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-04 | 116 | 49 | 3 | 27201cb805fe73b5ec51d7d585d047a4c043e8b0 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-04 | 116 | 49 | 3 | d3194bda2e3d5fd021e4015eed98c5888befe03d | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-04 | 116 | 49 | 3 | 4e84b6f6661bb5ba0fe0de38a23bee9cc3727d94 | |
| ToppCell | Substantia_nigra-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-04 | 116 | 49 | 3 | 15d9a3d8c3cc1f6a1aead03cf84dc876c76b7063 | |
| ToppCell | TCGA-Thymus-Solid_Tissue_Normal|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.19e-04 | 121 | 49 | 3 | 2c61d21eed1a587fc07b27737d87fc53678f4b3d | |
| ToppCell | TCGA-Thymus-Solid_Tissue_Normal-Thymus_normal_tissue-Thymus_normal_tissue|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.19e-04 | 121 | 49 | 3 | cb413b8b79e2f10f630dc2c3bcd9dc28f9eefb19 | |
| ToppCell | TCGA-Thymus-Solid_Tissue_Normal-Thymus_normal_tissue|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.19e-04 | 121 | 49 | 3 | df3bf1a7ff7706a4c30c703b33ade2c68583966e | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.60e-04 | 126 | 49 | 3 | 84dce108561d4b745d19250c2ac0667d9e4ea17d | |
| ToppCell | primary_visual_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.94e-04 | 130 | 49 | 3 | 3a0846b74ba34bd0e2a05b4f1f39f3940df93780 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.40e-04 | 135 | 49 | 3 | 9f9d0787a2e99207a9caa88a85565189ab8b940a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-5|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.59e-04 | 137 | 49 | 3 | a7c76201b8901b2ef7ebbb4dfe0cec0dc4534ef5 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-04 | 140 | 49 | 3 | 7ca49bd7ba9381e75c10f888775df17e5d46804d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-04 | 140 | 49 | 3 | 1a31bc33d5723b9bc528cc0047ca5f4c80531c7a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-04 | 142 | 49 | 3 | bf4a9633d128805a0d7e426d6fe6c29db1ff8c81 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.42e-04 | 145 | 49 | 3 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.53e-04 | 146 | 49 | 3 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.75e-04 | 148 | 49 | 3 | d3ea907f8f408e9bb97ed223a3089e403e35f911 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.75e-04 | 148 | 49 | 3 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.75e-04 | 148 | 49 | 3 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.75e-04 | 148 | 49 | 3 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.75e-04 | 148 | 49 | 3 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.75e-04 | 148 | 49 | 3 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.21e-04 | 152 | 49 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 153 | 49 | 3 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-04 | 153 | 49 | 3 | 98670bbce4a770af244f033cdd2d54db57200ca8 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 153 | 49 | 3 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 153 | 49 | 3 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.70e-04 | 156 | 49 | 3 | 8353f98e7d393d4299ed1da8f66cfbc7176df1b5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.70e-04 | 156 | 49 | 3 | 27590a4d2b419644966f0037c67c761fc275e0aa | |
| ToppCell | Globus_pallidus-Hematopoietic|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.70e-04 | 156 | 49 | 3 | 67cdaadc3b917f7072adce16c0391472c14a2563 | |
| ToppCell | Frontal_cortex-Hematopoietic|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.21e-04 | 160 | 49 | 3 | 70ffbe61cfd729519b23569a43d929b117ab8d5e | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.34e-04 | 161 | 49 | 3 | 8937f6b92cb2a93ea8c4780d9200a518c3112e53 | |
| ToppCell | facs-Aorta-Heart-18m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 162 | 49 | 3 | a6c6b953156c2e393d6ef5c3228eae90c472dda6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-04 | 162 | 49 | 3 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 163 | 49 | 3 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | facs-Aorta-Heart-18m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 163 | 49 | 3 | ae9dd2daf06ad0b78f666617f6b070ec3ecc13d8 | |
| ToppCell | facs-Aorta-Heart-18m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 163 | 49 | 3 | ee94242a048fc62b85be85eca2442e13553cbfb7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-04 | 164 | 49 | 3 | 1642a67c66eeb77a218e7814e3cfe517d9822955 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-04 | 164 | 49 | 3 | 25758fb8112baf296264122d5d4121f1ebb3d0fa | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 165 | 49 | 3 | 518ee34c18065100a2f2c6e407d3a7866b908593 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 165 | 49 | 3 | becb8f726b84509ec29c75b530a3fe757651301d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 165 | 49 | 3 | ae8dd9c00f96590f27ed21cd6314f4577e00e312 | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid-myeloid_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 166 | 49 | 3 | 8395c74db8e4e54af97a3f2b75cb75171140ec31 | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 166 | 49 | 3 | 76807edc5620514b53a14be354b84c54c112b8f9 | |
| ToppCell | facs-SCAT-Fat-3m-Myeloid-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 166 | 49 | 3 | 645b842b94b8d2f4b26c2623f8589f56bd782c26 | |
| ToppCell | Thalamus-Hematopoietic|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.02e-04 | 166 | 49 | 3 | 76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b | |
| Computational | Genes in the cancer module 289. | 2.90e-08 | 124 | 29 | 7 | MODULE_289 | |
| Computational | Genes in the cancer module 134. | 1.12e-06 | 30 | 29 | 4 | MODULE_134 | |
| Computational | Genes in the cancer module 288. | 2.65e-06 | 37 | 29 | 4 | MODULE_288 | |
| Computational | Genes in the cancer module 146. | 6.91e-06 | 102 | 29 | 5 | MODULE_146 | |
| Computational | Genes in the cancer module 27. | 3.36e-05 | 355 | 29 | 7 | MODULE_27 | |
| Computational | GPCR signaling pathways (immune and neuro). | 9.30e-05 | 90 | 29 | 4 | MODULE_375 | |
| Computational | Vesicular transport / synapse genes. | 1.36e-03 | 82 | 29 | 3 | MODULE_274 | |
| Drug | Neuropeptide Ff | 3.41e-07 | 69 | 48 | 5 | CID000123797 | |
| Drug | GTP[S] | 3.46e-07 | 591 | 48 | 10 | CID000001764 | |
| Drug | SNC-121 | 4.89e-07 | 8 | 48 | 3 | CID000197687 | |
| Drug | Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol | 7.18e-07 | 80 | 48 | 5 | CID004488326 | |
| Drug | Morphine | 3.87e-06 | 446 | 48 | 8 | ctd:D009020 | |
| Drug | erinacine E | 4.35e-06 | 2 | 48 | 2 | CID005317180 | |
| Drug | Dynorphin (1-11) | 4.35e-06 | 2 | 48 | 2 | CID003086114 | |
| Drug | (-)-EKC | 4.35e-06 | 2 | 48 | 2 | CID000042800 | |
| Drug | trefentanil | 4.35e-06 | 2 | 48 | 2 | CID000060727 | |
| Drug | 2-aminooxazole | 4.35e-06 | 2 | 48 | 2 | CID000558521 | |
| Drug | MR-1353 | 4.35e-06 | 2 | 48 | 2 | CID000197198 | |
| Drug | morphine hydrochloride | 6.73e-06 | 481 | 48 | 8 | CID000004253 | |
| Drug | Substance P | 7.17e-06 | 343 | 48 | 7 | CID000036511 | |
| Drug | trimebutine | 8.32e-06 | 19 | 48 | 3 | CID000005573 | |
| Drug | GI-1 | 8.83e-06 | 133 | 48 | 5 | CID011957431 | |
| Drug | Biphalin | 1.14e-05 | 21 | 48 | 3 | CID005487663 | |
| Drug | cyclorphan | 1.30e-05 | 3 | 48 | 2 | ctd:C084603 | |
| Drug | up hit | 1.30e-05 | 3 | 48 | 2 | CID000129713 | |
| Drug | TRK 820 | 1.30e-05 | 3 | 48 | 2 | ctd:C111212 | |
| Drug | Oxycodone | 1.30e-05 | 3 | 48 | 2 | DB00497 | |
| Drug | Hydromorphone | 1.30e-05 | 3 | 48 | 2 | DB00327 | |
| Drug | Codeine | 1.30e-05 | 3 | 48 | 2 | DB00318 | |
| Drug | Carfentanil | 1.30e-05 | 3 | 48 | 2 | DB01535 | |
| Drug | Morphine | 1.30e-05 | 3 | 48 | 2 | DB00295 | |
| Drug | Hydrocodone | 1.30e-05 | 3 | 48 | 2 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 1.30e-05 | 3 | 48 | 2 | DB01571 | |
| Drug | Alvimopan | 1.30e-05 | 3 | 48 | 2 | DB06274 | |
| Drug | dextrallorphan | 1.30e-05 | 3 | 48 | 2 | ctd:C044130 | |
| Drug | Heroin | 1.30e-05 | 3 | 48 | 2 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 1.30e-05 | 3 | 48 | 2 | DB01439 | |
| Drug | 14-phenylpropoxymetopon | 1.30e-05 | 3 | 48 | 2 | ctd:C478565 | |
| Drug | morphine-7,8-oxide | 1.30e-05 | 3 | 48 | 2 | CID005491901 | |
| Drug | Levorphanol | 1.30e-05 | 3 | 48 | 2 | ctd:D007981 | |
| Drug | Levallorphan | 1.30e-05 | 3 | 48 | 2 | ctd:D007977 | |
| Drug | NSC612112 | 1.30e-05 | 3 | 48 | 2 | CID000356432 | |
| Drug | NSC11411 | 1.30e-05 | 3 | 48 | 2 | CID000408117 | |
| Drug | indolin-3-one | 1.30e-05 | 3 | 48 | 2 | CID000230915 | |
| Drug | naloxazine | 1.30e-05 | 3 | 48 | 2 | CID003081567 | |
| Drug | Buprenorphine | 1.30e-05 | 3 | 48 | 2 | DB00921 | |
| Drug | Levorphanol | 1.30e-05 | 3 | 48 | 2 | DB00854 | |
| Drug | Remifentanil | 1.30e-05 | 3 | 48 | 2 | DB00899 | |
| Drug | Nalbuphine | 1.30e-05 | 3 | 48 | 2 | DB00844 | |
| Drug | Fentanyl | 1.30e-05 | 3 | 48 | 2 | DB00813 | |
| Drug | Sufentanil | 1.30e-05 | 3 | 48 | 2 | DB00708 | |
| Drug | Ro 64-6198 | 1.30e-05 | 3 | 48 | 2 | CID009844019 | |
| Drug | Propoxyphene | 1.30e-05 | 3 | 48 | 2 | DB00647 | |
| Drug | Butorphanol | 1.30e-05 | 3 | 48 | 2 | DB00611 | |
| Drug | Butorphanol | 1.30e-05 | 3 | 48 | 2 | ctd:D002077 | |
| Drug | guanine | 1.51e-05 | 902 | 48 | 10 | CID000000764 | |
| Drug | naltrexone HCl | 1.52e-05 | 71 | 48 | 4 | CID000004428 | |
| Drug | melanostatin | 2.21e-05 | 26 | 48 | 3 | CID000092910 | |
| Drug | pseudococaine | 2.29e-05 | 570 | 48 | 8 | CID000002826 | |
| Drug | AC1MLTDX | 2.48e-05 | 27 | 48 | 3 | CID003250242 | |
| Drug | EN-1530 | 2.51e-05 | 278 | 48 | 6 | CID000004425 | |
| Drug | Dynorphins | 2.60e-05 | 4 | 48 | 2 | ctd:D004399 | |
| Drug | AC1L5BQM | 2.60e-05 | 4 | 48 | 2 | CID000174892 | |
| Drug | Diprenorphine | 2.60e-05 | 4 | 48 | 2 | DB01548 | |
| Drug | 3B-b | 2.60e-05 | 4 | 48 | 2 | CID000533975 | |
| Drug | picenadol | 2.60e-05 | 4 | 48 | 2 | CID000053076 | |
| Drug | sulforhodamine B acid chloride | 2.60e-05 | 4 | 48 | 2 | CID000065223 | |
| Drug | Methadyl Acetate | 2.60e-05 | 4 | 48 | 2 | ctd:D008692 | |
| Drug | 7-hydroxymitragynine | 2.60e-05 | 4 | 48 | 2 | ctd:C482678 | |
| Drug | Naltrexone | 2.60e-05 | 4 | 48 | 2 | DB00704 | |
| Drug | thiorphan | 3.56e-05 | 88 | 48 | 4 | CID000003132 | |
| Drug | 1-acetyl-sn-glycero-3-phosphocholine | 4.21e-05 | 305 | 48 | 6 | CID005311264 | |
| Drug | myo-inositol | 4.25e-05 | 811 | 48 | 9 | CID000000892 | |
| Drug | K 185 | 4.33e-05 | 5 | 48 | 2 | CID005311198 | |
| Drug | AC1L2FKQ | 4.33e-05 | 5 | 48 | 2 | CID000020114 | |
| Drug | Tyr-tic-phe-phe-OH | 4.33e-05 | 5 | 48 | 2 | CID003035452 | |
| Drug | Dihydromorphine | 4.33e-05 | 5 | 48 | 2 | DB01565 | |
| Drug | ICI 197067 | 4.33e-05 | 5 | 48 | 2 | CID003081077 | |
| Drug | metkephamid acetate | 4.33e-05 | 5 | 48 | 2 | CID005464183 | |
| Drug | R-84760 | 4.33e-05 | 5 | 48 | 2 | CID000133035 | |
| Drug | Naloxone | 4.33e-05 | 5 | 48 | 2 | DB01183 | |
| Drug | DALECK | 4.33e-05 | 5 | 48 | 2 | CID015942760 | |
| Drug | GPA 1657 | 4.33e-05 | 5 | 48 | 2 | CID000030503 | |
| Drug | oxymorphamine | 4.33e-05 | 5 | 48 | 2 | CID000134844 | |
| Drug | RLH-033 | 4.33e-05 | 5 | 48 | 2 | CID000190867 | |
| Drug | mirfentanil | 4.33e-05 | 5 | 48 | 2 | CID000060697 | |
| Drug | Sc 39566 | 4.33e-05 | 5 | 48 | 2 | CID000130018 | |
| Drug | BRL 52537 | 4.33e-05 | 5 | 48 | 2 | CID005244802 | |
| Drug | AC1L1TDW | 4.33e-05 | 5 | 48 | 2 | CID000060509 | |
| Drug | Mr2097 | 4.33e-05 | 5 | 48 | 2 | CID005745592 | |
| Drug | Picrotoxin | 4.61e-05 | 94 | 48 | 4 | ctd:D010852 | |
| Drug | P3c-sk4 | 5.03e-05 | 34 | 48 | 3 | CID000130704 | |
| Drug | NSC612113 | 5.03e-05 | 34 | 48 | 3 | CID000004424 | |
| Drug | Pyr-his-gly | 5.49e-05 | 35 | 48 | 3 | CID000122313 | |
| Drug | DSLET | 5.49e-05 | 35 | 48 | 3 | CID000107847 | |
| Drug | Gi-2 | 5.56e-05 | 195 | 48 | 5 | CID011957432 | |
| Drug | AC1L9NAZ | 5.98e-05 | 198 | 48 | 5 | CID000449606 | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 5.98e-05 | 198 | 48 | 5 | 4158_UP | |
| Drug | AC1L2TFU | 6.49e-05 | 6 | 48 | 2 | CID000128241 | |
| Drug | Etorphine | 6.49e-05 | 6 | 48 | 2 | DB01497 | |
| Drug | NIH10236 | 6.49e-05 | 6 | 48 | 2 | CID006439828 | |
| Drug | DuP 747 | 6.49e-05 | 6 | 48 | 2 | CID000132447 | |
| Drug | AC1L2OET | 6.49e-05 | 6 | 48 | 2 | CID000125331 | |
| Drug | AC1L3OP4 | 6.49e-05 | 6 | 48 | 2 | CID000092720 | |
| Drug | beta-methyl-2',6'-dimethyltyrosine | 6.49e-05 | 6 | 48 | 2 | CID000189865 | |
| Drug | NSC612111 | 6.49e-05 | 6 | 48 | 2 | CID000163346 | |
| Drug | AC1L1FBI | 6.49e-05 | 6 | 48 | 2 | CID000053641 | |
| Disease | Alcoholic Intoxication, Chronic | 1.98e-10 | 268 | 44 | 9 | C0001973 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 3.00e-10 | 8 | 44 | 4 | DOID:1858 (implicated_via_orthology) | |
| Disease | Withdrawal Symptoms | 2.52e-08 | 58 | 44 | 5 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.52e-08 | 58 | 44 | 5 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.52e-08 | 58 | 44 | 5 | C0038587 | |
| Disease | Alcohol abuse | 5.26e-08 | 67 | 44 | 5 | C0085762 | |
| Disease | Alcohol Use Disorder | 5.59e-07 | 44 | 44 | 4 | C0001956 | |
| Disease | Mood Disorders | 5.11e-06 | 168 | 44 | 5 | C0525045 | |
| Disease | Modic type vertebral endplate changes | 1.68e-04 | 13 | 44 | 2 | HP_0030775 | |
| Disease | Hysterical amnesia | 2.91e-04 | 17 | 44 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 2.91e-04 | 17 | 44 | 2 | C0233796 | |
| Disease | Amnesia | 2.91e-04 | 17 | 44 | 2 | C0002622 | |
| Disease | Tactile Amnesia | 2.91e-04 | 17 | 44 | 2 | C0750906 | |
| Disease | Amnestic State | 2.91e-04 | 17 | 44 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 2.91e-04 | 17 | 44 | 2 | C0236795 | |
| Disease | Global Amnesia | 2.91e-04 | 17 | 44 | 2 | C0262497 | |
| Disease | Minimal Brain Dysfunction | 4.93e-04 | 22 | 44 | 2 | C1321905 | |
| Disease | Attention Deficit Disorder | 4.93e-04 | 22 | 44 | 2 | C0041671 | |
| Disease | Mental Depression | 5.55e-04 | 254 | 44 | 4 | C0011570 | |
| Disease | Anhedonia | 5.87e-04 | 24 | 44 | 2 | C0178417 | |
| Disease | Attention deficit hyperactivity disorder | 5.87e-04 | 24 | 44 | 2 | C1263846 | |
| Disease | Bradycardia | 6.90e-04 | 26 | 44 | 2 | C0428977 | |
| Disease | glutamate measurement | 8.60e-04 | 29 | 44 | 2 | EFO_0010487 | |
| Disease | asthma (is_marker_for) | 8.86e-04 | 126 | 44 | 3 | DOID:2841 (is_marker_for) | |
| Disease | Depressive disorder | 8.99e-04 | 289 | 44 | 4 | C0011581 | |
| Disease | pulmonary sarcoidosis (is_marker_for) | 1.05e-03 | 32 | 44 | 2 | DOID:13406 (is_marker_for) | |
| Disease | Cocaine Dependence | 1.18e-03 | 139 | 44 | 3 | C0600427 | |
| Disease | body weights and measures | 1.48e-03 | 38 | 44 | 2 | EFO_0004324 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VWLFSPFCHCTFVIG | 356 | Q8WWZ7 | |
| VVAFALCWTPYHLVV | 261 | P49682 | |
| SFAEVHSWVVFCLPE | 516 | Q8IWZ6 | |
| VETVVLFFPDVWHCL | 566 | Q8IX12 | |
| AHLACAFLWVVVAVA | 176 | Q13304 | |
| SWVFGVHFCKLIFAI | 121 | P32248 | |
| ALAVIWSHECVVCFF | 261 | Q3LIE5 | |
| LWVICSHFFTVHIPA | 21 | Q5VUY0 | |
| VVVAVFLVCWTPYHI | 381 | Q16581 | |
| VTVVALFAVCWAPFH | 276 | Q96P65 | |
| WIHCFEGVTAIIFCV | 211 | P63096 | |
| VCVVVVFAVSWLPLH | 271 | P49146 | |
| SPYCFISAEVVHWLV | 1201 | O75140 | |
| AANCATHAFWIIPSI | 36 | Q8IY49 | |
| VLVVVFGICWAPFHA | 301 | Q9HB89 | |
| FVLVLVFAICWAPFH | 271 | Q9GZQ4 | |
| WIHCFEGVTAIIFCV | 211 | P08754 | |
| RAVVIAFVVCWLPYH | 306 | P30989 | |
| WEIHHFFCEVPAVTI | 176 | Q6IEZ7 | |
| CVIFVSISWAVGVLH | 141 | Q8NGD4 | |
| CVVLVLISWFVGFIH | 141 | Q8NH41 | |
| LLCWTPFFVVHITQA | 356 | P21917 | |
| VVGAFVVCWAPIHIF | 266 | P41143 | |
| VVCWAPIHIFVIVWT | 271 | P41143 | |
| WEIHHFFCEVPAVTI | 176 | Q8NH02 | |
| VHVLNFWCLNPAVAF | 586 | Q9BX63 | |
| WVFVIFHAIPEIHCT | 281 | Q9NZH0 | |
| KWIHCFEGVTAIIFC | 211 | P19086 | |
| TAIVVGFFVCWAPYH | 236 | Q9P296 | |
| VIWAVAFCSAGPIFV | 166 | Q92847 | |
| AVVVFAFILCWLPFH | 266 | Q92847 | |
| VATIWFPVCAHRETT | 136 | O75508 | |
| LFACISFCHIWAVVP | 91 | P56539 | |
| FDFAVWACIAAAIPV | 561 | Q9ULK0 | |
| TLLFSATCPHWVFNV | 371 | Q9NR30 | |
| IWVCPVSDHVCTRFF | 581 | Q2NL67 | |
| FEICHPVVDVTWFYS | 1181 | Q6ZRI0 | |
| AVFVVCWTPIHIFIL | 281 | P41145 | |
| LVASFFLCWFPNHVV | 251 | Q8TDU9 | |
| VLCVWCFFSRPHFTV | 156 | P59533 | |
| FHSWRVFVIVCALPC | 316 | Q496J9 | |
| FIICFVPHHVVQLPW | 241 | P25105 | |
| KWIHCFEGVTAIIFC | 211 | P04899 | |
| IVVVCTFAICWLPFH | 251 | P25103 | |
| HSWRVFVLVCAFPSV | 331 | Q7L0J3 | |
| VVVAFVVCWTPYHLF | 251 | P46091 | |
| RFPIWVVCSESHFSI | 666 | Q4G0A6 | |
| AVIIQFCWHFFTIAA | 371 | Q5GH76 | |
| VACFLHPVLVWHVTI | 101 | A0PK05 | |
| GVFFCKAPIHWTNVV | 3106 | Q5THJ4 |